Publications by authors named "Dmitri Sviridov"

Apoptotic cell death is regulated by the BCL-2 protein family, with clusters of BAK or BAX homodimers driving pore formation in the mitochondrial outer membrane via a poorly understood process. There is growing evidence that, in addition to BAK and BAX, lipids play an important role in pore formation. Towards a better understanding of the lipidic drivers of apoptotic pore formation in isolated mitochondria, two complementary approaches were taken.

View Article and Find Full Text PDF
Article Synopsis
  • Oxy210, an oxysterol-based drug, shows promise in treating atherosclerosis and NASH due to its antifibrotic and anti-inflammatory effects.
  • In studies with a special mouse model and cell types, Oxy210 significantly reduced atherosclerotic lesions and inflammatory markers related to atherosclerosis.
  • The results indicate that Oxy210 may be an effective drug candidate for tackling both NASH and atherosclerosis, along with related chronic inflammation.
View Article and Find Full Text PDF

Background: Among people living with HIV-1 (PHIV), immunological non-responders (INR) experience incomplete immune recovery despite suppressive antiretroviral treatment (ART), facing more severe non-AIDS events than immunological responders (IR) due to higher chronic immune activation and inflammation (cIA/I). We analyzed the HIV-1 reservoir and immunometabolism in monocytes as a source of cIA/I.

Methods: Cross-sectional study in which 110 participants were enrolled: 25 treatment-naïve; 35 INR; 40 IR; and 10 healthy controls.

View Article and Find Full Text PDF

Extracellular vesicles (EVs) serve as pivotal mediators of intercellular communication in both health and disease, delivering biologically active molecules from vesicle-producing cells to recipient cells. In the context of HIV infection, EVs have been shown to carry the viral protein Nef, a key pathogenic factor associated with HIV-related co-morbidities. Despite this recognition, the specific localisation of Nef within the vesicles has remained elusive.

View Article and Find Full Text PDF
Article Synopsis
  • HIV-associated neurocognitive disorders (HAND) refer to cognitive impairments linked to HIV infection, affecting over 50% of people living with HIV even with effective antiretroviral therapy (ART).
  • Various factors like ongoing HIV replication and neuroinflammation have been studied as potential causes of HAND, but the exact mechanisms remain unclear.
  • The text suggests that the HIV-1 protein Nef may disrupt cholesterol homeostasis in the brain, potentially unifying the different contributing factors to HAND and offering new therapeutic targeting opportunities.
View Article and Find Full Text PDF
Article Synopsis
  • - The study explores "trained immunity" in HIV-infected individuals, suggesting that hyperreactive myeloid cells contribute to chronic inflammation even under anti-retroviral treatment.
  • - Human monocyte-derived macrophages treated with HIV-1 protein Nef release more pro-inflammatory cytokines after stimulation, due to chromatin changes affecting inflammation and cholesterol metabolism.
  • - Both bone-marrow-derived macrophages from exNef-treated mice and those transplanted with exNef bone marrow show increased production of tumor necrosis factor α (TNF-α), which reflects the persistent inflammatory response linked to HIV infection.
View Article and Find Full Text PDF

Findings that certain infections induce immunity not only against the causing agent, but also against an unrelated pathogen have intrigued investigators for many years. Recently, underlying mechanisms of this phenomenon have started to come to light. It was found that the key cells responsible for heterologous protection are innate immune cells such as natural killer cells (NKs), dendritic cells, and monocytes/macrophages.

View Article and Find Full Text PDF

HIV-associated neurocognitive disorders (HAND) is a term used to describe a variety of neurological impairments observed in HIV-infected individuals. The pathogenic mechanisms of HAND and of its connection to HIV infection remain unknown, but one of the considered hypotheses suggests that HIV infection accelerates the development of Alzheimer's disease. Previous studies suggested that HIV-1 Nef may contribute to HAND by inhibiting cholesterol efflux, increasing the abundance of lipid rafts, and affecting their functionality.

View Article and Find Full Text PDF

HIV-1 infection impairs cellular cholesterol efflux by downmodulating the cholesterol transporter ABCA1, leading to metabolic co-morbidities like cardio-vascular disease. The main mechanism of this effect is impairment by the HIV-1 protein Nef of the ABCA1 interaction with the endoplasmic reticulum chaperone calnexin, which leads to a block in ABCA1 maturation followed by its degradation. However, ABCA1 is also downmodulated by Nef delivered with the extracellular vesicles, suggesting involvement of a direct Nef:ABCA1 interaction at the plasma membrane.

View Article and Find Full Text PDF

Chronic HIV infection may exacerbate atherosclerotic vascular disease, which at advanced stages presents as necrotic plaques rich in crystalline cholesterol. Such lesions can catastrophically rupture precipitating myocardial infarct and stroke, now important causes of mortality in those living with HIV. However, in this population little is known about plaque structure relative to crystalline content and its chemical composition.

View Article and Find Full Text PDF

Lipid rafts are distinct liquid-ordered domains of plasma membranes of most eukaryotic cells providing platform for signaling pathways. Lipid composition of rafts is critical for their structural integrity and for regulation of signaling pathways originating from rafts. Here we provide a protocol to isolate lipid rafts from cultured human and animal cells and comprehensively analyse their lipid composition.

View Article and Find Full Text PDF

Low-grade persistent inflammation is a feature of diabetes-driven vascular complications, in particular activation of the Nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome to trigger the maturation and release of the inflammatory cytokine interleukin-1β (IL-1β). We investigated whether inhibiting the NLRP3 inflammasome, through the use of the specific small-molecule NLRP3 inhibitor MCC950, could reduce inflammation, improve vascular function, and protect against diabetes-associated atherosclerosis in the streptozotocin-induced diabetic apolipoprotein E-knockout mouse. Diabetes led to an approximately fourfold increase in atherosclerotic lesions throughout the aorta, which were significantly attenuated with MCC950 ( < 0.

View Article and Find Full Text PDF

Sterol 27-hydroxylase (CYP27A1) is a key enzyme in bile acids (BAs) biosynthesis and a regulator of cholesterol metabolism. double knockout (DKO) mice fed with western diet (WD) are protected from atherosclerosis up-regulation of hepatic and . Since feeding BAs ameliorates metabolic changes in KO mice, we tested BAs feeding on the development of atherosclerosis in DKO mice.

View Article and Find Full Text PDF

COVID-19 is a global pandemic currently in an acute phase of rapid expansion. While public health measures remain the most effective protection strategy at this stage, when the peak passes, it will leave in its wake important health problems. Historically, very few viruses have ever been eradicated.

View Article and Find Full Text PDF

Lipoproteins play a key role in transport of cholesterol to and from tissues. Recent studies have also demonstrated that red blood cells (RBCs), which carry large quantities of free cholesterol in their membrane, play an important role in reverse cholesterol transport. However, the exact role of RBCs in systemic cholesterol metabolism is poorly understood.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate how HIV infection and combined antiretroviral therapy (c-ART) impact proatherogenic biomarkers and lipids, and their links to early signs of atherosclerosis in treatment-naive patients.
  • A comparative analysis was conducted with two groups of HIV-infected patients (one starting c-ART and the other not) alongside healthy controls, with various biomarkers measured at different time points using lab tests and carotid ultrasounds.
  • Results indicated that HIV-infected patients initially had poorer lipid profiles and higher inflammatory markers; however, those starting c-ART showed improvements in certain lipid levels and reductions in inflammatory markers over time, while signs of atherosclerosis increased in both groups of HIV patients.
View Article and Find Full Text PDF

Objective: AIBP (apolipoprotein A-I binding protein) is an effective and selective regulator of lipid rafts modulating many metabolic pathways originating from the rafts, including inflammation. The mechanism of action was suggested to involve stimulation by AIBP of cholesterol efflux, depleting rafts of cholesterol, which is essential for lipid raft integrity. Here we describe a different mechanism contributing to the regulation of lipid rafts by AIBP.

View Article and Find Full Text PDF
Article Synopsis
  • HANDs are common in individuals with HIV, and while treatment has improved outcomes, the overall prevalence remains unchanged, indicating ongoing issues even with viral suppression.
  • The study found that HIV-1 protein Nef, when secreted in extracellular vesicles, disrupts neuronal function by decreasing ABCA1 levels and altering lipid raft composition, leading to the accumulation of proteins like APP and Tau.
  • These alterations are linked to inflammatory responses and ultimately impair neuronal function, suggesting that the interaction between Nef and cholesterol trafficking may play a crucial role in the development of neurocognitive disorders in HIV-infected individuals.
View Article and Find Full Text PDF

Drug repurposing is potentially the fastest available option in the race to identify safe and efficacious drugs that can be used to prevent and/or treat COVID-19. By describing the life cycle of the newly emergent coronavirus, SARS-CoV-2, in light of emerging data on the therapeutic efficacy of various repurposed antimicrobials undergoing testing against the virus, we highlight in this review a possible mechanistic convergence between some of these tested compounds. Specifically, we propose that the lysosomotropic effects of hydroxychloroquine and several other drugs undergoing testing may be responsible for their demonstrated in vitro antiviral activities against COVID-19.

View Article and Find Full Text PDF

Lipid rafts regulate the initiation of cellular metabolic and signaling pathways by organizing the pathway components in ordered microdomains on the cell surface. Cellular responses regulated by lipid rafts range from physiological to pathological, and the success of a therapeutic approach targeting "pathological" lipid rafts depends on the ability of a remedial agent to recognize them and disrupt pathological lipid rafts without affecting normal raft-dependent cellular functions. In this article, concluding the Thematic Review Series on Biology of Lipid Rafts, we review current experimental therapies targeting pathological lipid rafts, including examples of inflammarafts and clusters of apoptotic signaling molecule-enriched rafts.

View Article and Find Full Text PDF

Dysregulation of lipid homeostasis is intimately associated with defects in insulin secretion, a key feature of type 2 diabetes. Here, we explore the role of the putative lipid transporter ABCA12 in regulating insulin secretion from β-cells. Mice with β-cell-specific deletion of Abca12 display impaired glucose-stimulated insulin secretion and eventual islet inflammation and β-cell death.

View Article and Find Full Text PDF
Article Synopsis
  • AIBP (Apolipoprotein A-I binding protein) regulates lipid rafts and cholesterol efflux, and is shown to inhibit HIV replication by reducing lipid raft abundance and virus-cell fusion.
  • Exogenously added AIBP was more effective in macrophages compared to T cells, and the presence of Nef proteins in the virus or exosomes is necessary for AIBP to inhibit HIV fusion with MDMs.
  • Donors with the HLA-B*35 genotype, linked to rapid HIV disease progression, showed lower binding of AIBP, resulting in increased HIV replication, highlighting the role of AIBP as an innate factor in limiting HIV spread.
View Article and Find Full Text PDF

: Combination antiretroviral therapy has dramatically changed the outcome of HIV infection, turning it from a death sentence to a manageable chronic disease. However, comorbidities accompanying HIV infection, such as metabolic and cardio-vascular diseases, as well as cognitive impairment, persist despite successful virus control by combination antiretroviral therapy and pose considerable challenges to clinical management of people living with HIV. These comorbidities involve a number of pathological processes affecting a variety of different tissues and cells, making it challenging to identify a common cause(s) that would link these different diseases to HIV infection.

View Article and Find Full Text PDF